The economic impact of the diagnosis of dysplasia in Barrett's esophagus

American Journal of Gastroenterology

Volumn 95, Issue 10, 2000, Pages 2946-2952

  Ofman, Joshua J ^a,d   Lewin, Klaus ^b   Ramers, Christian ^b   Ippoliti, Andy ^b   Lieberman, David ^c   Weinstein, Wilfred ^b  

^a Zynx Health   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; RANITIDINE;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DYSPLASIA; ENDOSCOPIC BIOPSY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTI-ULCER AGENTS; BARRETT ESOPHAGUS; BIOPSY; COST-BENEFIT ANALYSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; RANITIDINE; RISK ASSESSMENT;

EID: 0033784968     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02002-5     Document Type: Article

References (21)

1. The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years
2. Etiology of Barrett's metaplasia and esophageal adenocarcinoma
3. The epidemiology of esophageal carcinoma. The changing face of a disease
4. The increasing frequency of adenocarcinoma of the esophagus
5. Barrett's esophagus: The biology of neoplastic progression
6. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions
7. Observer variation in the diagnosis of dysplasia in Barrett's esophagus
8. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus
9. Photodynamic therapy for Barrett's esophagus
10. A guide for surveillance of patients with Barrett's esophagus
11. The diagnosis of Barrett's esophagus: Goblets, goblets, goblets
12. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications
13. Gastric epithelial dysplasia in the natural history of gastric cancer: A multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia
14. Barrett's oesophagus and p53
15. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?
16. Barrett's esophagus: Does the incidence of adenocarcinoma matter?
17. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus
18. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia
19. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction
20. Endoscopic surveillance of Barrett's esophagus. Does it help?
21. Changing patterns and surgical results in adenocarcinoma of the oesophagus